{"title":"认识和诊断的提高被认为是促使SHA使用障碍增加的原因","authors":"Alison Knopf","doi":"10.1002/cbl.30868","DOIUrl":null,"url":null,"abstract":"<p>Substance use disorders (SUDs) specific to sedative, hypnotic, or anxiolytics — have increased by 3- to 5-times among adolescent and young adult enrollees of Medicaid from 2001 to 2019, but prevalence remained low among adolescents, researchers have found. The study attributed the increase in use disorders of these medications, many of which are benzodiazepines, to the increase in availability of these medications, as well as to the increased awareness and detection of these disorders.</p>","PeriodicalId":101223,"journal":{"name":"The Brown University Child and Adolescent Behavior Letter","volume":"41 5","pages":"7"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Increase in awareness and diagnosis thought to drive increase in SHA use disorder\",\"authors\":\"Alison Knopf\",\"doi\":\"10.1002/cbl.30868\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Substance use disorders (SUDs) specific to sedative, hypnotic, or anxiolytics — have increased by 3- to 5-times among adolescent and young adult enrollees of Medicaid from 2001 to 2019, but prevalence remained low among adolescents, researchers have found. The study attributed the increase in use disorders of these medications, many of which are benzodiazepines, to the increase in availability of these medications, as well as to the increased awareness and detection of these disorders.</p>\",\"PeriodicalId\":101223,\"journal\":{\"name\":\"The Brown University Child and Adolescent Behavior Letter\",\"volume\":\"41 5\",\"pages\":\"7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Brown University Child and Adolescent Behavior Letter\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cbl.30868\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Child and Adolescent Behavior Letter","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cbl.30868","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Increase in awareness and diagnosis thought to drive increase in SHA use disorder
Substance use disorders (SUDs) specific to sedative, hypnotic, or anxiolytics — have increased by 3- to 5-times among adolescent and young adult enrollees of Medicaid from 2001 to 2019, but prevalence remained low among adolescents, researchers have found. The study attributed the increase in use disorders of these medications, many of which are benzodiazepines, to the increase in availability of these medications, as well as to the increased awareness and detection of these disorders.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
